Delivery Order SPE2DX15D8003-SPE2DX24F7B8D

Award Date 11/28/23

Potential Completion Date 11/29/23

Potential Value $6.5K

Federal Agency

Medical Supply Chain

Awardee

Dakota Drug, Inc. H544BCGUKW64

Ultimate Awardee

Not listed

NAICS Category

424210 - Drugs and Druggists' Sundries Merchant Wholesalers

PSC Category

6505 - Drugs And Biologicals

Federal Contract Vehicle

Not listed

Set-Aside Type

No Set-Aside Used

Extent Competed

Full and Open Competition

Major Defense Program

Not listed

Pricing Type

Firm Fixed Price

Place of Performance

Anoka, MN, USA

Solicitation Procedures

Negotiated Proposal / Quote

Number Of Offers Received

Not listed

Legislative Mandate

Not listed

National Interest Action

Not listed

Research Type

Not listed

Primary Consortia Member

Not listed

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business, for the provision of CONCERTA ER 54 MG TABLET 100S, a pharmaceutical product. The contract has a firm fixed price of $6,476.13 and a performance period extending through November 29, 2023. The award is not associated with a set-aside program. Dakota Drug, Inc. holds a significant Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999.00, which allows the company to provide a comprehensive range of pharmaceutical products, medical supplies, and healthcare equipment to support U.S. Armed Forces medical operations through the DLA Troop Support Medical's ECAT Generation V Program. This delivery order contract is a part of the company's larger strategic role as a key supplier for the Defense Logistics Agency's medical supply chain needs.

Generated 5/12/25, 9:58 AM